🇺🇸 FDA
Patent

US 8158675

Compounds and methods for the treatment or prevention of Flavivirus infections

granted A61PA61P1/16A61P31/12

Quick answer

US patent 8158675 (Compounds and methods for the treatment or prevention of Flavivirus infections) held by Vertex Pharmaceuticals (Canada) Incorporated expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals (Canada) Incorporated
Grant date
Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/16, A61P31/12, A61P31/14, A61P37/02